Differential Roles of Costimulatory Signaling Pathways in Type 1 Diabetes Mellitus

Editorial

Rev Diabet Stud, 2004, 1(4):156-164

DOI 10.1900/RDS.2004.1.156

Differential Roles of Costimulatory Signaling Pathways in Type 1 Diabetes Mellitus

Bernhard O. Boehm¹, Jeffrey A. Bluestone²

¹Division of Endocrinology and Diabetes, Department of Internal Medicine, University of Ulm, Germany
²Diabetes Center, Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Address correspondence to: Bernhard O. Boehm, e-mail: bernhard.boehm@medizin.uni-ulm.de

Abstract

n/a

Fulltext: HTML , PDF (336KB)

This article has been cited by other articles:

	A proinsulin74-90-derived protease-resistant, altered peptide ligand increases TGF-beta1 secretion in PBMC from patients with type 1 diabetes mellitus van Aalst D, Kalbacher H, Palesch D, Zou F, Spyrantis A, Rosinger S, Boehm BO, Burster T J Leukoc Biol 2010. 87(5):943-948

	Protease-resistant human GAD-derived altered peptide ligands decrease TNF-alpha and IL-17 production in peripheral blood cells from patients with type 1 diabetes mellitus Boehm BO, Rosinger S, Sauer G, Manfras BJ, Palesch D, Schiekofer S, Kalbacher H, Burster T Mol Immunol 2009. 46(13):2576-2584

	Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes Endl J, Rosinger S, Schwarz B, Friedrich SO, Rothe G, Karges W, Schlosser M, Eiermann T, Schendel DJ, Boehm BO Diabetes 2006. 55(1):50-60

	Genetic Susceptibility to Type 1 Diabetes in the Intracellular Pathway of Antigen Processing – A Subject Review and Cross-Study Comparison Sia C, Weinem M Rev Diabet Stud 2005. 2(1):40-52

	The Role of Regulatory T Cell Defects in Type I Diabetes and the Potential of these Cells for Therapy Thomas D, Zaccone P, Cooke A Rev Diabet Stud 2005. 2(1):9-18